Heroin | Jotup

How the ‘Mexican miracle’ kickstarted the modern US–Mexico drugs trade

Retrieved on:

Wednesday, April 10, 2024

The flow of cheap and deadly fentanyl over the border into the US has also fuelled an opioid epidemic that has killed over 1 million Americans since 2000.

Key Points:

The flow of cheap and deadly fentanyl over the border into the US has also fuelled an opioid epidemic that has killed over 1 million Americans since 2000.
It is a dark side to the so-called “Mexican miracle” that transformed the country’s economy between the 1940s and 1970s.
Stimulated by the Mexican and US governments’ promotion of infrastructure improvements and mass migration, the drug trade fuelled further lawful economic development throughout the country.

Cops, cartels and cash crops

Many of Durango’s battled-scarred and poverty-stricken former miners adapted to the national and global turbulence by turning to opium poppies, a profitable (and since 1920, illegal) cash crop.
Sap from opium poppies provides the raw material for drugs like morphine and heroin.
In response, US officials like Harry J. Anslinger promoted a “crusade” against the drug trade on both sides of the border.
In 1944, a joint US–Mexican expedition uncovered the largest opium plantation ever discovered in Mexico: the size of 325 football pitches.

Cold war Mexico

As the second world war gave way to the cold war, Latin American countries (often with US financial assistance) promoted urbanisation, industrialisation, infrastructural expansion, population growth and transnational economic integration.
Between 1950 and 1970, Mexico’s one-party state invested massively in public services and industrial and agricultural development.
But they helped connect the poppy fields of Durango to the rest of northern Mexico and the US border too.

The ‘heroin highway’

It consolidated Durango’s importance as a Mexican drug-production centre and transformed Chicago into the biggest heroin-trafficking hub on the continent.
The cash that trafficking organisations earned wholesaling heroin in the US was reinvested locally in everything from cattle ranches to construction companies and even an airline.

Instead, these were completely intertwined with the economic growth, infrastructure development and mass migration that characterised the Mexican miracle.
The story of the modern US–Mexican drug trade is not just about brutal violence and lives cut tragically short.

Nathaniel Morris received part of the funding for this research from the Leverlhulme Trust. He is affiliated with the Mexico & Central America Program of Noria Research.

Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

Retrieved on:

Tuesday, April 2, 2024

The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ (“AMS Technology”).

Key Points:

The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ (“AMS Technology”).
Currently, the Company’s Tracer 1000 ETD is now found in multiple locations in 14 countries throughout the world.
“We are extremely excited to share our user-friendly mass spectrometer the TRACER 1000, which is powered by our AMS Technology, with leading industry experts and security industry professionals at the ISC West conference.
The TRACER 1000 is the first mass spectrometry-based ETD to have received European Civil Aviation Conference (“ECAC”) certification for both checkpoint and cargo security.

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

Retrieved on:

Thursday, March 28, 2024

FSA, U.S. FDA, Arm, Heroin, Risk, Education, Pharmacy, School, Naloxone, Policy, EBS, Flexible, House, Drug, OTC, CDC, Restaurant, Medicaid, National Safety Council, AED, HSA, FDA, Emergent BioSolutions, NSC, Medicine, Fentanyl, Pharmaceutical industry

Emergent and other stakeholders in the fight must continue raising awareness about the availability of products like NARCAN® Nasal Spray, reducing stigma and further improving access for all Americans.

Key Points:

Emergent and other stakeholders in the fight must continue raising awareness about the availability of products like NARCAN® Nasal Spray, reducing stigma and further improving access for all Americans.
Since the OTC launch, NARCAN® Nasal Spray can be purchased at more than 32,000 mass drug, grocery, online retailers and e-commerce sites.
Emergent is working with retail partners to make it easy to find and access, however each retailer ultimately determines in-store product placement.
“That’s why we remain committed to increasing awareness of NARCAN® Nasal Spray availability.

Astrotech Introduces the “Gold Standard” of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000

Retrieved on:

Monday, March 25, 2024

Astrotech, Conference, Heroin, Cocaine, ETD, Law enforcement, NTD, Prison, European Civil Aviation Conference, Airport, Mass spectrometry, ASTC, TRACER, Fentanyl, Drug

The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds.

Key Points:

The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds.
Currently, the Company’s Tracer 1000 Explosive Trace Detector (ETD) is now found in multiple locations in 14 countries throughout the world.
The Astrotech Mass Spectrometer Technology™ (AMS Technology) drives the breakthrough TRACER 1000, as the first certified ETD to employ mass spectrometry as a trace detection security solution.
The TRACER 1000 is the only mass spectrometry-based ETD to have received European Civil Aviation Conference certification for both checkpoint and cargo security.

908 Devices Trace Chemical Identification Technology Adopted by European Agencies

Retrieved on:

Tuesday, March 12, 2024

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats.

Key Points:

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats.
A contract was awarded to 908 Devices and the first two units shipped in recent months to Belgium and Greece, with more units expected to be procured.
908 Devices is also conducting target development work for an additional 15 targets identified by the DrugDetect EU project.
“We’re honored to partner with the NATO Support and Procurement Agency and DrugDetect EU project as they work to advance detection and identification of chemical threats across Europe,” said Kevin J. Knopp, CEO and co-founder of 908 Devices.

Combatting Overdoses: The SPOT's Mission to Prevent Spring Break Deaths

Retrieved on:

Tuesday, March 12, 2024

Heroin, Xylazine, HIV, Risk, COVID-19, Naloxone, Hope, Fentanyl, Syringe, STI, Accidental, Drug, CDC, Safety, SPOT, HCV, Pharmaceutical industry

Emelina Martinez, Safe Syringe Exchange Services Manager for The SPOT, states, "Many spring breakers don't realize that the substances they are purchasing on the street might be laced with fentanyl or xylazine.

Key Points:

Emelina Martinez, Safe Syringe Exchange Services Manager for The SPOT, states, "Many spring breakers don't realize that the substances they are purchasing on the street might be laced with fentanyl or xylazine.
Our goal is to reach more people this year, distributing more Narcan with the hope of saving even more lives."
This emphasizes the critical need for awareness and harm reduction efforts, such as those undertaken by The SPOT, to mitigate the negative consequences of substance use during spring break and beyond.
In addition to its primary mission of harm reduction, The SPOT operates as a mobile medical clinic, offering a range of free medical services.

Gallus Medical Detox Is Now In-Network with Blue Cross Blue Shield of Texas

Retrieved on:

Tuesday, February 27, 2024

Insurance, Medicaid, Medicare, Heroin, Health, Patient, Pharmaceutical industry

Dallas-Fort Worth, Texas--(Newsfile Corp. - February 27, 2024) - Gallus Medical Detox, a provider of in-patient medical detoxification services for patients suffering from severe drug and alcohol addictions, including alcohol detox , suboxone detox and heroin detox in addition to a wide variety of other addictive substances, is pleased to announce another milestone in making its clinics as affordable as possible.

Key Points:

Dallas-Fort Worth, Texas--(Newsfile Corp. - February 27, 2024) - Gallus Medical Detox, a provider of in-patient medical detoxification services for patients suffering from severe drug and alcohol addictions, including alcohol detox , suboxone detox and heroin detox in addition to a wide variety of other addictive substances, is pleased to announce another milestone in making its clinics as affordable as possible.
Effective February 1st, Gallus Medical Detox in its clinic conveniently located midway between Dallas and Fort Worth in Mansfield, Texas became an In-Network provider with Blue Cross Blue Shield of Texas in addition to accepting private insurance on an out-of-network basis with almost all major insurance carriers and also accepting private pay patients.
Gallus does not accept Medicaid or Medicare.
From our start in Arizona and then the opening of our Denver detox clinic and now with the addition of our Texas location being in-network with Blue Cross Blue Shield of Texas we continue to help more people access our facilities and our highest quality patient care."

Methamphetamine Use Reaches All-Time High in People Who Use Fentanyl with No Signs of Slowing, Adding Fuel to U.S. Fentanyl Crisis

Retrieved on:

Wednesday, February 21, 2024

View the full release here: https://www.businesswire.com/news/home/20240220752791/en/

Key Points:

View the full release here: https://www.businesswire.com/news/home/20240220752791/en/
Shifting trends in the co-detection of prescription opioids, heroin, methamphetamine, and cocaine nationally provide insight into how each has changed over time.
More recently, a fourth wave of overdose deaths co-involving fentanyl with stimulants like methamphetamine and cocaine has emerged.
Stimulants were co-involved in over 30% of fentanyl overdose deaths in 2021, up from less than 1% in 2010.
Millennium Health’s Signals Report shows that UDT data tightly correlate with U.S. overdose mortality rates and closely follow the evolution of America’s fentanyl crisis.

Anonymous Health Expands Innovative Addiction Care Services to Oregon

Retrieved on:

Wednesday, February 21, 2024

Fentanyl, MAT, Addiction medicine, Heroin, Cocaine, Interest, Nicotine, Health, Anonymous, Internal medicine, Patient, Senior counsel, Case management, Providence Health & Services, Addiction

PORTLAND, Ore., Feb. 21, 2024 /PRNewswire/ -- Anonymous Health, a pioneer in outpatient teletherapy services, is proud to announce its statewide expansion across Oregon.

Key Points:

PORTLAND, Ore., Feb. 21, 2024 /PRNewswire/ -- Anonymous Health, a pioneer in outpatient teletherapy services, is proud to announce its statewide expansion across Oregon.
"We are excited to help address long-standing capacity and access challenges of addiction care in Oregon, including in rural communities," said Medical Director, Dr. Palani Chidambaram.
"(1) Dr. Chidambaram is Board certified in Internal Medicine and Addiction Medicine, and he founded and leads the addiction medicine practice at several Providence Health System hospitals in the Portland, Oregon region.
Personalized Care and Advanced Technology: Anonymous Health's Approach
Patients at Anonymous Health receive near-immediate attention from a dedicated Concierge Care Manager.

Too much heat in the kitchen: survey shows toxic work conditions mean many chefs are getting out

Retrieved on:

Friday, March 8, 2024

Umbrella, Innovation, Mental health, Restaurant, Student, Cocaine, Heroin, Fatigue, LSD, Incivility, Suicide, Tourism, MBIE, Culture, Sleep, Bear, Long COVID, Government, Mental, Methamphetamine, History, COVID, Policy, Legislation, Meal, Theft, Depression

“Chefs, chefs, chefs!

Key Points:

“Chefs, chefs, chefs!
Australia is seeing a similar gap, with chefs ranked the eighth most in-demand occupation.
Our study is the first quantitative survey to examine working conditions and mental health issues among chefs in both Australia and New Zealand.
The survey also followed up previous Australian studies, which indicated exploitation was an industry norm, with chefs experiencing burnout and wage theft.

‘Banter, bollockings and beatings’

As one British study titled “Banter, bollockings and beatings” made clear, an often macho culture can prevail, including bizarre induction rituals.
An Australian study published in 2022 showed chefs were significantly more likely than the general population to commit suicide.
And even before the pandemic, the industry’s “toxic” workplace culture was blamed for mental health issues and high suicide rates among employees.
Two-thirds (67%) of respondents worked more than 38 hours weekly, but a fifth of the chefs worked 52-61 hours.

Leaving the industry

Results showed high levels of physical and mental fatigue (“exhausted at work”, “emotionally drained”, “becoming disconnected”).
The majority of respondents said they were likely (with 20% extremely likely) to look for a new employer during the next year.
Read more:
All these celebrity restaurant wage-theft scandals point to an industry norm

Mental health and healthy hospo

The Better Work Action Plan, the first phase of New Zealand’s Tourism Industry Transformation Plan, was launched by MBIE in 2023 under the previous government.
It followed extensive consultation with representatives from hospitality and tourism, Māori, unions, workers and government.
Its aim was to develop a sustainable tourism workforce by addressing longstanding issues of low pay and poor conditions across the sector.
By chance, however, New Zealand’s new minister for mental health, Matt Doocey, is also tourism and hospitality minister.

The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.